Delivery Order SPE2DB22D3301-SPE2DB24FZ3CR

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution subsidiary of Amerisourcebergen Corporation. The $2,706.47 firm fixed-price contract is for the delivery of 4556823177 - OCELLA 3 MG-0.03 MG TABLET 28S, with a completion date of April 8, 2022. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,114.94 firm fixed-price contract is for the delivery of OCELLA 3 MG-0.03 MG TABLET 28S, a prescription medication. The contract has an ultimate completion date of June 30, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,308.80 Firm Fixed Price delivery order contract is for the supply of OCELLA 3 MG-0.03 MG TABLET 28S, a pharmaceutical product. The contract has an Ultimate Completion Date of August 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the pharmaceutical product OCELLA 3 MG-0.03 MG TABLET 28S, with a ceiling value of $1,997.12 and a period of performance through October 16, 2024. The contract is a firm-fixed-price type and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,436.09 firm fixed-price delivery order is for OCELLA 3 MG-0.03 MG TABLET 28S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,617.47 firm fixed-price delivery order is for the supply of OCELLA 3 MG-0.03 MG tablets, a medical product used in healthcare. The award has an ultimate completion date of October 18, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,203.32 firm-fixed-price delivery order contract is for the supply of OCELLA 3 MG-0.03 MG TABLET 28S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,882.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of OCELLA 3 MG-0.03 MG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of April 13, 2023 and is a Firm Fixed Price (FFP) contract. The contract was not designated with any set-aside requirements, indicating open...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at two hundred thirty-five dollars and fifty-six cents to Amerisourcebergen Drug Corporation for the supply of 3 mg-0.03 mg Ocella tablets. Amerisourcebergen Drug Corporation will deliver twenty-eight tablets from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements by July 27, 2023 under the contract start and end dates. As a leading provider of pharmaceuticals and healthcare value-added...
The Defense Logistics Agency awarded a delivery order valued at $478.46 to Amerisourcebergen Drug Corp under an indefinite-delivery/indefinite-quantity contract vehicle. The delivery order is for 4561868207 OCELLA 3 MG-0.03 MG TABLET 28S to be delivered to a facility in Conshohocken, Pennsylvania by August 21, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will serve as the prime contractor. The Defense Logistics Agency manages the global supply...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ3CR
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,953.38 firm fixed-price contract is for the supply of 4565483040 Ocella 3 mg-0.03 mg tablet 28s, a prescription pharmaceutical product. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and veterans' healthcare programs. The company holds several Indefinite Delivery Contracts (IDCs) with DLA and other agencies, valued up to $999,999,999 and $750,000, respectively, for delivering a broad range of critical medical commodities. This specific delivery order does not have a set-aside designation.

Generated 11/15/24, 9:25 AM